))
57- Dr Ruth Payne- When flexibility mattered
Manage episode 402172648 series 3399637
Content provided by Dr Sandrine Soubes. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Sandrine Soubes or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Dr Ruth Payne has a dual professional identity as a Consultant Microbiologist for the National Health Services (UK) as well as a Senior Clinical Lecturer at the University of Sheffield. Her interest in malaria vaccines may have been the starting point for her research career, but her expertise in vaccines became the corner stone of her ability to contribute to the Covid vaccine development efforts.
Ruth entered the world of research as a doctor following her appointment on a research fellowship position that became her PhD work at the Jenner Institute, University of Oxford (2012 - 2016). Her interest in malaria and vaccine development is anchored in a childhood spent in East Africa and in seeing first-hand the impact of this disease. After her research fellowship/PhD, she went back full time to a clinical role in Nottingham before jumping into a Clinical Academic Lectureship position.
Ruth calls herself “an accidental academic” and admits that it was the inspiring and supportive approach of her academic manager/ PhD supervisor during her research fellowship position and PhD that led her to continue a career that embraced both clinical work and research.
Building a research team is never easy but establishing yourself as a new PI when you work 50% time as a clinician and 50% time in research, and then on top of that a world pandemic is forcing you to stop your research…well that is quite a start when you are a new Principal Investigator.
This challenging period has brought her resilience and connections. During the Covid period, her experience in vaccine development enabled her to get involved in many new vaccine clinical trials projects, that she could never have predicted. It allowed her to jump into new projects and build very close working relationships with many new colleagues. It created opportunities to be involved at a national level in policies related to vaccine development (e.g., UK Clinical Vaccine Network, Covid19 task force of the British Society of Immunology).
Listening to our conversation will prompt your thinking:
· How embracing the silver lining of the Covid pandemic created more opportunities and exposure than ever
· How embedding yourself into larger projects creates the economy of scale needed when you get started as a new PI
· Why keeping lines of communication within your network increases your opportunities
75 episodes
Share
